Vilanterol trifenatate

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Vilanterol trifenatate

CAS No. : 503070-58-4

MCE 国际站：Vilanterol trifenatate

产品活性：Vilanterol trifenatate (GW642444 trifenatate) 是一种长效的 β₂-AR 激动剂，效力持续24小时。 对β₂-AR，β₁-AR和β₃-AR的 pEC₅₀ 分别为10.37，6.98 ，7.36。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：Adrenergic Receptor

In Vitro: The selectivity of Vilanterol trifenatate for β₂-AR over the other β-AR receptor subtypes (β₂ and β₃) is established by testing the ability of Vilanterol to elicit concentration-dependent increases in cAMP in CHO cells expressing human β₁-, β₂-, and β₃-AR. Vilanterol is demonstrated to be highly selective for the β₂-AR with at least a 1000-fold selectivity over both β₂- and β₃-AR subtypes. This analysis results in a low-affinity pK_D for [³H]Vilanterol of 9.44±0.07 (n=4) in the presence Gpp(NH)p and a high-affinity pK_D of 10.82±0.12 (n=4) and a low-affinity pK_D 9.47±0.17 (n=4) in the absence of Gpp(NH)p. In addition, a low-affinity pK_D for [³H]Vilanterol of 9.52±0.24 (n=4) in the absence of Gpp(NH)p (37°C) is observed. Vilanterol trifenatate is a novel inhaled long-acting β₂-agonist with inherent 24 h activity in vitro in development as a combination with the inhaled corticosteroid fluticasone furoate for both COPD and asthma. Vilanterol is a novel long-acting β₂-agonist (LABA) with inherent 24-hour activity for once-daily clinical treatment of chronic obstructive pulmonary disease (COPD) and asthma in combination with the inhaled novel corticosteroid fluticasone furoate, also active for 24 hours.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  Neuronal Signaling Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Drug Repurposing Compound Library  |  Endocrinology Compound Library  |  Anti-COVID-19 Compound Library  |  NMPA-Approved Drug Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Obesity Compound Library  |  Antidepressant Compound Library  |  Protein-protein Interaction Inhibitor Library  |  EMA-Approved Drug Library  |  FDA-Approved Anticancer Drug Library  |  Off-patent Drug Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Isoprenaline hydrochloride  |  Norepinephrine  |  Zenidolol hydrochloride  |  Propranolol hydrochloride  |  Phenylephrine  |  CL 316243  |  Metoprolol  |  Carvedilol  |  L-Epinephrine  |  Atenolol  |  Pimozide  |  Prazosin hydrochloride  |  Clozapine  |  Amitriptyline hydrochloride  |  Nadolol  |  Yohimbine  |  Olanzapine  |  Brexpiprazole  |  Dexmedetomidine  |  2',5'-Dideoxyadenosine  |  Mirabegron  |  Salmeterol  |  SR59230A  |  YS-49

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds